{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:57:17Z","timestamp":1793649437660,"version":"4.5.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41423-020-00623-2","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:36:34Z","timestamp":1610638594000},"page":"698-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Induced regulatory T cells suppress Tc1 cells through TGF-\u03b2 signaling to ameliorate STZ-induced type 1 diabetes mellitus"],"prefix":"10.1038","volume":"18","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongdong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chichu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-6114","authenticated-orcid":false,"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"623_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2019","unstructured":"Patterson, C. C. et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia 62, 408\u201317. (2019).","journal-title":"Diabetologia"},{"key":"623_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone, S. J. et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 313, 37\u201344 (2015).","journal-title":"JAMA"},{"key":"623_CR3","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2337\/db18-0065","volume":"67","author":"CJ Greenbaum","year":"2018","unstructured":"Greenbaum, C. J. et al. Strength in numbers: opportunities for enhancing the development of effective treatments for type 1 diabetes\u2014the TrialNet experience. Diabetes 67, 1216\u201325. (2018).","journal-title":"Diabetes"},{"key":"623_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5, 219\u201326. (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"623_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","volume":"155","author":"A Willcox","year":"2009","unstructured":"Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K. & Morgan, N. G. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173\u201381. (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"623_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","volume":"209","author":"KT Coppieters","year":"2012","unstructured":"Coppieters, K. T. et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 209, 51\u201360 (2012).","journal-title":"J. Exp. Med."},{"key":"623_CR7","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.2337\/dc14-0316","volume":"37","author":"B Menart-Houtermans","year":"2014","unstructured":"Menart-Houtermans, B. et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 37, 2326\u201333. (2014).","journal-title":"Diabetes Care"},{"key":"623_CR8","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.4049\/jimmunol.165.11.6314","volume":"165","author":"C Vizler","year":"2000","unstructured":"Vizler, C. et al. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J. Immunol. 165, 6314\u201321. (2000).","journal-title":"J. Immunol."},{"key":"623_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"JH Buckner","year":"2010","unstructured":"Buckner, J. H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10, 849\u201359. (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"623_CR10","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2337\/db11-0090","volume":"60","author":"A Ferraro","year":"2011","unstructured":"Ferraro, A. et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60, 2903\u201313. (2011).","journal-title":"Diabetes"},{"key":"623_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.humimm.2013.01.024","volume":"74","author":"M Ryba-Stanislawowska","year":"2013","unstructured":"Ryba-Stanislawowska, M., Skrzypkowska, M., Mysliwiec, M. & Mysliwska, J. Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. Hum. Immunol. 74, 701\u2013707 (2013).","journal-title":"Hum. Immunol."},{"key":"623_CR12","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2337\/diabetes.54.4.1040","volume":"54","author":"D Lundsgaard","year":"2005","unstructured":"Lundsgaard, D., Holm, T. L., Hornum, L. & Markholst, H. In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3. Diabetes 54, 1040\u20131047 (2005).","journal-title":"Diabetes"},{"key":"623_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/diabetes.54.2.306","volume":"54","author":"E Jaeckel","year":"2005","unstructured":"Jaeckel, E., von Boehmer, H. & Manns, M. P. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54, 306\u201310. (2005).","journal-title":"Diabetes"},{"key":"623_CR14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc12-0038","volume":"35","author":"N Marek-Trzonkowska","year":"2012","unstructured":"Marek-Trzonkowska, N. et al. Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35, 1817\u201320. (2012).","journal-title":"Diabetes Care"},{"key":"623_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","volume":"29","author":"DA Horwitz","year":"2008","unstructured":"Horwitz, D. A., Zheng, S. G. & Gray, J. D. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29, 429\u201335. (2008).","journal-title":"Trends Immunol."},{"key":"623_CR16","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.4049\/jimmunol.1000598","volume":"185","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J. Immunol. 185, 2675\u20132679 (2010).","journal-title":"J. Immunol."},{"key":"623_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368 (2014).","journal-title":"Nat. Med."},{"key":"623_CR18","doi-asserted-by":"publisher","first-page":"e40314","DOI":"10.1371\/journal.pone.0040314","volume":"7","author":"W Xu","year":"2012","unstructured":"Xu, W. et al. Adoptive transfer of induced-Treg cells effectively attenuates murine airway allergic inflammation. Plos One 7, e40314 (2012).","journal-title":"Plos One"},{"key":"623_CR19","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.4049\/jimmunol.180.11.7112","volume":"180","author":"SG Zheng","year":"2008","unstructured":"Zheng, S. G., Wang, J. & Horwitz, D. A. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 180, 7112\u20137116 (2008).","journal-title":"J. Immunol."},{"key":"623_CR20","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","volume":"178","author":"L Xu","year":"2007","unstructured":"Xu, L., Kitani, A., Fuss, I. & Strober, W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725\u20136729 (2007).","journal-title":"J. Immunol."},{"key":"623_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","volume":"4","author":"Q Lan","year":"2012","unstructured":"Lan, Q. et al. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J. Mol. Cell Biol. 4, 22\u201328 (2012).","journal-title":"J. Mol. Cell Biol."},{"key":"623_CR22","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2011-201052","volume":"71","author":"N Kong","year":"2012","unstructured":"Kong, N. et al. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann. Rheum. Dis. 71, 1567\u201372. (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"623_CR23","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1002\/art.34513","volume":"64","author":"N Kong","year":"2012","unstructured":"Kong, N. et al. Antigen-specific transforming growth factor \u03b2-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17\/Treg cell balance from Th17 predominance to Treg cell predominance. Arthritis Rheum. 64, 2548\u201358. (2012).","journal-title":"Arthritis Rheum."},{"key":"623_CR24","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.4049\/jimmunol.180.5.2830","volume":"180","author":"RK Selvaraj","year":"2008","unstructured":"Selvaraj, R. K. & Geiger, T. L. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 180, 2830\u20132838 (2008).","journal-title":"J. Immunol."},{"key":"623_CR25","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.4049\/jimmunol.176.8.4730","volume":"176","author":"SE Weber","year":"2006","unstructured":"Weber, S. E. et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 176, 4730\u20134739 (2006).","journal-title":"J. Immunol."},{"key":"623_CR26","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1073\/pnas.0611646104","volume":"104","author":"X Luo","year":"2007","unstructured":"Luo, X. et al. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl Acad. Sci. USA 104, 2821\u20132826 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"623_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clim.2014.05.006","volume":"153","author":"CB Jones","year":"2014","unstructured":"Jones, C. B. et al. Regulatory T cells control diabetes without compromising acute anti-viral defense. Clin. Immunol. 153, 298\u2013307 (2014).","journal-title":"Clin. Immunol."},{"key":"623_CR28","doi-asserted-by":"publisher","first-page":"992","DOI":"10.2337\/diab.43.8.992","volume":"43","author":"D Elias","year":"1994","unstructured":"Elias, D. et al. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 43, 992\u2013998 (1994).","journal-title":"Diabetes"},{"key":"623_CR29","first-page":"585","volume":"70","author":"G Kantwerk","year":"1987","unstructured":"Kantwerk, G., Cobbold, S., Waldmann, H. & Kolb, H. L. 3T. 4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice. Clin. Exp. Immunol. 70, 585\u2013592 (1987).","journal-title":"Clin. Exp. Immunol."},{"key":"623_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/diab.33.9.894","volume":"33","author":"M Nakamura","year":"1984","unstructured":"Nakamura, M., Nagafuchi, S., Yamaguchi, K. & Takaki, R. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice. Diabetes 33, 894\u2013900 (1984).","journal-title":"Diabetes"},{"key":"623_CR31","first-page":"277","volume":"86C","author":"K Buschard","year":"1978","unstructured":"Buschard, K. & Rygaard, J. T-lymphocytes transfer streptozotocin induced diabetes mellitus in mice. Acta Pathol. Microbiol Scand. C 86C, 277\u201382. (1978).","journal-title":"Acta Pathol. Microbiol Scand. C"},{"key":"623_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","volume":"244","author":"SN Goyal","year":"2016","unstructured":"Goyal, S. N. et al. Challenges and issues with streptozotocin-induced diabetes\u2014a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem. Biol. Interact. 244, 49\u201363 (2016).","journal-title":"Chem. Biol. Interact."},{"key":"623_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15857-x","volume":"11","author":"C Shimokawa","year":"2020","unstructured":"Shimokawa, C. et al. CD8(+) regulatory T cells are critical in prevention of autoimmune-mediated diabetes. Nat. Commun. 11, 1922 (2020).","journal-title":"Nat. Commun."},{"key":"623_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1078\/0171-2985-00109","volume":"205","author":"A M\u00fcller","year":"2002","unstructured":"M\u00fcller, A., Schott-Ohly, P., Dohle, C. & Gleichmann, H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL\/6 and BALB\/c mice by multiple low doses of streptozotocin. Immunobiology 205, 35\u201350 (2002).","journal-title":"Immunobiology"},{"key":"623_CR35","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/intimm\/12.7.1075","volume":"12","author":"S Kondo","year":"2000","unstructured":"Kondo, S. et al. Suppression of insulitis and diabetes in B cell-deficient mice treated with streptozocin: B cells are essential for the TCR clonotype spreading of islet-infiltrating T cells. Int Immunol. 12, 1075\u201383. (2000).","journal-title":"Int Immunol."},{"key":"623_CR36","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1186\/s12974-019-1557-6","volume":"16","author":"W Cai","year":"2019","unstructured":"Cai, W. et al. All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signaling. J. Neuroinflamm. 16, e175 (2019).","journal-title":"J. Neuroinflamm."},{"key":"623_CR37","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.20120822","volume":"209","author":"M Yadav","year":"2012","unstructured":"Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713\u20131722 (2012). S1\u201319.","journal-title":"J. Exp. Med."},{"key":"623_CR38","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.4049\/jimmunol.172.9.5213","volume":"172","author":"SG Zheng","year":"2004","unstructured":"Zheng, S. G., Wang, J. H., Gray, J. D., Soucier, H. & Horwitz, D. A. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172, 5213\u201321. (2004).","journal-title":"J. Immunol."},{"key":"623_CR39","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.4049\/jimmunol.1501740","volume":"196","author":"A Xu","year":"2016","unstructured":"Xu, A. et al. TGF-beta-induced regulatory T cells directly suppress B cell responses through a noncytotoxic mechanism. J. Immunol. 196, 3631\u201341. (2016).","journal-title":"J. Immunol."},{"key":"623_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","volume":"460","author":"K Araki","year":"2009","unstructured":"Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108\u201312. (2009).","journal-title":"Nature"},{"key":"623_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.immuni.2009.10.010","volume":"32","author":"RR Rao","year":"2010","unstructured":"Rao, R. R., Li, Q., Odunsi, K. & Shrikant, P. A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32, 67\u201378 (2010).","journal-title":"Immunity"},{"key":"623_CR42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4049\/jimmunol.1403038","volume":"195","author":"D Ito","year":"2015","unstructured":"Ito, D. et al. mTOR complex signaling through the SEMA4A\u2013Plexin B2 axis is required for optimal activation and differentiation of CD8+T cells. J. Immunol. 195, 934\u201343. (2015).","journal-title":"J. Immunol."},{"key":"623_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12026-009-8137-2","volume":"47","author":"Q Yu","year":"2010","unstructured":"Yu, Q., Sharma, A. & Sen, J. M. TCF1 and \u03b2-catenin regulate T cell development and function. Immunol. Res 47, 45\u201355 (2010).","journal-title":"Immunol. Res"},{"key":"623_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.celrep.2016.10.013","volume":"17","author":"T Donnarumma","year":"2016","unstructured":"Donnarumma, T. et al. Opposing development of cytotoxic and follicular helper CD4 T cells controlled by the TCF-1-Bcl6 nexus. Cell Rep. 17, 1571\u201383. (2016).","journal-title":"Cell Rep."},{"key":"623_CR45","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.celrep.2018.01.072","volume":"22","author":"M Danilo","year":"2018","unstructured":"Danilo, M., Chennupati, V., Silva, J. G., Siegert, S. & Held, W. Suppression of Tcf1 by inflammatory cytokines facilitates effector CD8 T cell differentiation. Cell Rep. 22, 2107\u201317. (2018).","journal-title":"Cell Rep."},{"key":"623_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<176::AID-PATH433>3.0.CO;2-8","volume":"178","author":"BA O\u2019Brien","year":"1996","unstructured":"O\u2019Brien, B. A., Harmon, B. V., Cameron, D. P. & Allan, D. J. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J. Pathol. 178, 176\u201381. (1996).","journal-title":"J. Pathol."},{"key":"623_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.189.2.423","volume":"189","author":"A Cerwenka","year":"1999","unstructured":"Cerwenka, A., Morgan, T. M., Harmsen, A. G. & Dutton, R. W. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189, 423\u201334. (1999).","journal-title":"J. Exp. Med."},{"key":"623_CR48","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.4049\/jimmunol.1003265","volume":"186","author":"S Morlacchi","year":"2011","unstructured":"Morlacchi, S. et al. Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation. J. Immunol. 186, 6807\u201314. (2011).","journal-title":"J. Immunol."},{"key":"623_CR49","doi-asserted-by":"publisher","first-page":"e7696","DOI":"10.1371\/journal.pone.0007696","volume":"4","author":"V Dal Secco","year":"2009","unstructured":"Dal Secco, V. et al. Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes. Plos One 4, e7696 (2009).","journal-title":"Plos One"},{"key":"623_CR50","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.4049\/jimmunol.174.10.5950","volume":"174","author":"JT Lin","year":"2005","unstructured":"Lin, J. T., Martin, S. L., Xia, L. & Gorham, J. D. TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. J. Immunol. 174, 5950\u20135958 (2005).","journal-title":"J. Immunol."},{"key":"623_CR51","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1073\/pnas.1834400100","volume":"100","author":"EA Green","year":"2003","unstructured":"Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H. & Flavell, R. A. C. D. 4 CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878\u201383. (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"623_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.intimp.2018.12.051","volume":"68","author":"L Li","year":"2019","unstructured":"Li, L., Ma, Y. & Xu, Y. Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway. Int. Immunopharmacol. 68, 81\u201387 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"623_CR53","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.27277","volume":"60","author":"T Shirasaki","year":"2014","unstructured":"Shirasaki, T. et al. Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway. Hepatology 60, 1519\u201330. (2014).","journal-title":"Hepatology"},{"key":"623_CR54","doi-asserted-by":"publisher","first-page":"a19","DOI":"10.1126\/scisignal.aad1884","volume":"9","author":"S Viel","year":"2016","unstructured":"Viel, S. et al. TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci. Signal. 9, a19 (2016).","journal-title":"Sci. Signal."},{"key":"623_CR55","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ni.1762","volume":"10","author":"Q Yu","year":"2009","unstructured":"Yu, Q. et al. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat. Immunol. 10, 992\u2013999 (2009).","journal-title":"Nat. Immunol."},{"key":"623_CR56","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.4049\/jimmunol.1303417","volume":"193","author":"MM Tiemessen","year":"2014","unstructured":"Tiemessen, M. M. et al. T Cell factor 1 represses CD8+ effector T cell formation and function. J. Immunol. 193, 5480\u20135487 (2014).","journal-title":"J. Immunol."},{"key":"623_CR57","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20082286","volume":"206","author":"J Das","year":"2009","unstructured":"Das, J. et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 206, 2407\u201316. (2009).","journal-title":"J. Exp. Med."},{"key":"623_CR58","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.7150\/thno.47118","volume":"10","author":"THW Fung","year":"2020","unstructured":"Fung, T. H. W., Yang, K. Y. & Lui, K. O. An emerging role of regulatory T-cells in cardiovascular repair and regeneration. Theranostics 10, 8924\u201338. (2020).","journal-title":"Theranostics"},{"key":"623_CR59","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","volume":"155","author":"D Burzyn","year":"2013","unstructured":"Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282\u201395. (2013).","journal-title":"Cell"},{"key":"623_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1165\/rcmb.2017-0019OC","volume":"57","author":"CF Dial","year":"2017","unstructured":"Dial, C. F., Tune, M. K., Doerschuk, C. M. & Mock, J. R. Foxp3(+) regulatory T cell expression of keratinocyte growth factor enhances lung epithelial proliferation. Am. J. Respir. Cell Mol. Biol. 57, 162\u201373. (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"623_CR61","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nn.4528","volume":"20","author":"Y Dombrowski","year":"2017","unstructured":"Dombrowski, Y. et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nat. Neurosci. 20, 674\u201380. (2017).","journal-title":"Nat. Neurosci."},{"key":"623_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10169","volume":"475","author":"A Facciabene","year":"2011","unstructured":"Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 475, 226\u201330. (2011).","journal-title":"Nature"},{"key":"623_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","volume":"169","author":"N Ali","year":"2017","unstructured":"Ali, N. et al. Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell 169, 1119\u201329. (2017).","journal-title":"Cell"},{"key":"623_CR64","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/cvr\/cvu159","volume":"103","author":"R Sharir","year":"2014","unstructured":"Sharir, R. et al. Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner. Cardiovasc. Res. 103, 585\u201396. (2014).","journal-title":"Cardiovasc. Res."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00623-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00623-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00623-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T07:04:59Z","timestamp":1662447899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00623-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-00623-2","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests that might be perceived as influencing the results and\/or discussion in this paper. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}